| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Renton Hollings serves as a Director at ANAB. Across recent SEC filings that breaks down to 0 buys and 10 sells. Those positions are worth an estimated $288K at current prices.
Historically, Renton Hollings's trades have earned a below-average insider score of 33/100 across 6 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -50.1%.
The biggest single holding is ANAB (~$288K) as Director. The recent filings there lean toward selling, a net 61,121 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ANAB Anaptysbio, Inc. | Director | Sale+OE | 5,000 | $49.87 | $249,371.50 | -31.3% | - | - | |
| Aug 8, 2025 | ANAB Anaptysbio, Inc | Director | Sale+OE | 10,231 | $19.62 | $200,713.62 | -67.3% | +81.6% | +169.2% | |
| Jul 2, 2025 | ANAB Anaptysbio, Inc | Director | Sale+OE | 20,925 | $23.57 | $493,190.56 | -80.8% | +28.2% | +165.6% | |
| Jun 18, 2025 | ANAB Anaptysbio, Inc | - | Sell | 3,015 | $23.97 | $72,269.55 | -37.8% | -17.1% | +145.9% | |
| Nov 29, 2024 | ANAB Anaptysbio, Inc | Director | Sale+OE | 10,000 | $25.00 | $250,000.00 | -83.7% | -34.3% | +66.9% | |
| Jul 15, 2024 | ANAB Anaptysbio, Inc | Director | Sale+OE | 10,000 | $30.64 | $306,422.48 | -83.7% | +6.2% | -18.6% | |
| Jun 18, 2024 | ANAB Anaptysbio, Inc | Director | Sale+OE | 1,950 | $23.16 | $45,162.00 | -50.0% | +69.2% | +2.2% |